Quick Links

 Andrew Raubitschek, M.D.

  • Chair, Cancer Immunotherapeutics & Tumor Immunology
  • Co-leader, Cancer Immunotherapeutics Program, Comprehensive Cancer Center
  • Chief of Radioimmunotherapy, Radiation Oncology
  • Professor of Radiation Oncology

Dr. Raubitschek's research focuses on use of genetically engineered monoclonal antibodies. Antibody metabolism and interactions between chemotherapy and radioimmunotherapy to determine the effect of radioimmunotherapy on certain tumors.

Professional Experience

2005 - present, Chair, Department of Cancer Immunotherapeutics & Tumor Immunology, Beckman Research Institute of City of Hope, Duarte, CA

2003 - present, Professor, Department of Radiation Oncology, City of Hope, Duarte, CA

2002 - present, Co-leader, Cancer Immunotherapeutics Program, City of Hope Comprehensive Cancer Center, Duarte, CA

1991 - present, Chief, Division of Radioimmunotherapy, City of Hope, Duarte, CA

1991 - 2003, Associate Radiation Oncologist, Department of Radiation Oncology, City of Hope, Duarte, CA

1987 - 1991, Staff Physician, Radiation Oncology Branch-Cancer Expert, National Cancer Institute, Bethesda, MD

1985 - 1986, Medical Staff Fellow, Radiation Oncology Branch, National Cancer Institute, Bethesda, MD

1982 - 1985, Scientist, Cetus Immune Corporation, Palo Alto, CA

Education and Training

1985 - 1986, National Cancer Institute, Bethesda, Maryland , Residency, Radiation Oncology Branch

1979 - 1980, Stanford University, Palo Alto, California, Residency, Radiation Oncology

1978 - 1979, University of California San Francisco, California, Internship, Radiation Oncology

1978, University of California San Francisco, California, M.D.

1970, Princeton University, Princeton, New Jersey, A.B.

This is an abbreviated document. Full CV available upon request. Information on this page may be self-reported. Last updated: 12/08.

Andrew Raubitschek, M.D.
Professional Memberships

1996 - present, American Society of Clinical Oncology

1990 - present, American Society for Therapeutic Radiology and Oncology

1973 - present, American Association for the Advancement of Science


Board Certification

1989, American Board of Radiology - Therapeutic Radiology

 Search

Go!
Advanced Search Options
News & Publications Search

 Contact Information

To request expert commentary on Immunotherapy, Radiology or Targeted Therapeutics, contact Media Relations.

To reach me or my staff,
call 800-826-HOPE (4673).

 Learn More

NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.